comparison of glp 1 receptor agonists GLP-1 and DPP-4 inhibitors GLP-1 Drug Comparison in Diabetes

Macro vascular complications are still the primary cause of death in patients with T2DM.Glucagon like peptide-1 receptor agonists (GLP1-RAs) are a new class of Injectable Anti-diabetes Agents (IADA) that provides blood glucose control with weight reduction ability, systolic blood pressure reduction and a noticeable improvement of lipid profile

It increases how much insulin your pancreas produces, which naturally lowers your blood sugar

PMCID: PMC10684505

Semaglutide GLP-1 injections have also demonstrated cardiac benefits in the form of lowering blood pressure

Why FirmLabs Peptides is the best place to buy Semaglutide FirmLabs Peptides is more than just a trusted U.S